PDB Short entry for 5V5Z HEADER OXIDOREDUCTASE/OXIDOREDUCATSE INHIBITOR 15-MAR-17 5V5Z TITLE STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS COMPND MOL_ID: 1; COMPND 2 MOLECULE: LANOSTEROL 14-ALPHA DEMETHYLASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CYPLI,CYTOCHROME P450 51,CYTOCHROME P450-14DM,CYTOCHROME COMPND 5 P450-LIA1,STEROL 14-ALPHA DEMETHYLASE; COMPND 6 EC: 1.14.13.70; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CANDIDA ALBICANS (STRAIN SC5314 / ATCC MYA- SOURCE 3 2876); SOURCE 4 ORGANISM_COMMON: YEAST; SOURCE 5 ORGANISM_TAXID: 237561; SOURCE 6 STRAIN: SC5314 / ATCC MYA-2876; SOURCE 7 GENE: ERG11, CYP51, ERG16, CAALFM_C500660CA, CAO19.922; SOURCE 8 EXPRESSION_SYSTEM: SACCHAROMYCES CEREVISIAE; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 4932; SOURCE 10 EXPRESSION_SYSTEM_STRAIN: ADDELTA KEYWDS PATHOGEN, CANDIDA ALBICANS, CYP51, ITRACONAZOLE, OXIDOREDUCTASE- KEYWDS 2 OXIDOREDUCATSE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.V.KENIYA,M.SABHERWAL,R.K.WILSON,A.A.SAGATOVA,J.D.A.TYNDALL,B.C.MONK REVDAT 6 04-OCT-23 5V5Z 1 REMARK REVDAT 5 12-FEB-20 5V5Z 1 JRNL REVDAT 4 01-JAN-20 5V5Z 1 REMARK REVDAT 3 20-SEP-17 5V5Z 1 REMARK REVDAT 2 12-APR-17 5V5Z 1 TITLE REVDAT 1 29-MAR-17 5V5Z 0 JRNL AUTH M.V.KENIYA,M.SABHERWAL,R.K.WILSON,M.A.WOODS,A.A.SAGATOVA, JRNL AUTH 2 J.D.A.TYNDALL,B.C.MONK JRNL TITL CRYSTAL STRUCTURES OF FULL-LENGTH LANOSTEROL 14 JRNL TITL 2 ALPHA-DEMETHYLASES OF PROMINENT FUNGAL PATHOGENS CANDIDA JRNL TITL 3 ALBICANS AND CANDIDA GLABRATA PROVIDE TOOLS FOR ANTIFUNGAL JRNL TITL 4 DISCOVERY. JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 62 2018 JRNL REFN ESSN 1098-6596 JRNL PMID 30126961 JRNL DOI 10.1128/AAC.01134-18 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.A.SAGATOVA,M.V.KENIYA,R.K.WILSON,B.C.MONK,J.D.TYNDALL REMARK 1 TITL STRUCTURAL INSIGHTS INTO BINDING OF THE ANTIFUNGAL DRUG REMARK 1 TITL 2 FLUCONAZOLE TO SACCHAROMYCES CEREVISIAE LANOSTEROL REMARK 1 TITL 3 14ALPHA-DEMETHYLASE. REMARK 1 REF ANTIMICROB. AGENTS V. 59 4982 2015 REMARK 1 REF 2 CHEMOTHER. REMARK 1 REFN ESSN 1098-6596 REMARK 1 PMID 26055382 REMARK 1 DOI 10.1128/AAC.00925-15 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.C.MONK,T.M.TOMASIAK,M.V.KENIYA,F.U.HUSCHMANN,J.D.TYNDALL, REMARK 1 AUTH 2 J.D.O'CONNELL,R.D.CANNON,J.G.MCDONALD,A.RODRIGUEZ, REMARK 1 AUTH 3 J.S.FINER-MOORE,R.M.STROUD REMARK 1 TITL ARCHITECTURE OF A SINGLE MEMBRANE SPANNING CYTOCHROME P450 REMARK 1 TITL 2 SUGGESTS CONSTRAINTS THAT ORIENT THE CATALYTIC DOMAIN REMARK 1 TITL 3 RELATIVE TO A BILAYER. REMARK 1 REF PROC. NATL. ACAD. SCI. V. 111 3865 2014 REMARK 1 REF 2 U.S.A. REMARK 1 REFN ESSN 1091-6490 REMARK 1 PMID 24613931 REMARK 1 DOI 10.1073/PNAS.1324245111 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.51 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 19726 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.221 REMARK 3 R VALUE (WORKING SET) : 0.219 REMARK 3 FREE R VALUE : 0.269 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 968 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 44.5098 - 5.5448 1.00 2840 145 0.2098 0.2393 REMARK 3 2 5.5448 - 4.4023 1.00 2686 139 0.1864 0.2206 REMARK 3 3 4.4023 - 3.8462 1.00 2669 145 0.1892 0.2333 REMARK 3 4 3.8462 - 3.4947 1.00 2684 113 0.2042 0.3128 REMARK 3 5 3.4947 - 3.2443 1.00 2648 142 0.2336 0.3274 REMARK 3 6 3.2443 - 3.0530 1.00 2613 143 0.2982 0.3319 REMARK 3 7 3.0530 - 2.9002 1.00 2618 141 0.3517 0.3965 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.440 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 32.230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 4221 REMARK 3 ANGLE : 1.228 5740 REMARK 3 CHIRALITY : 0.061 597 REMARK 3 PLANARITY : 0.007 760 REMARK 3 DIHEDRAL : 16.256 2499 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5V5Z COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1000226917. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-FEB-15 REMARK 200 TEMPERATURE (KELVIN) : 91 REMARK 200 PH : 8.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.954 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19796 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 91.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 7.500 REMARK 200 R MERGE (I) : 0.20000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.08 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : 1.23500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4LXJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 64.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.5 M GLYCINE-NAOH, 35% PEG400,, PH REMARK 280 8.8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 46.25500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 50.76500 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 46.25500 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 50.76500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ILE A 3 REMARK 465 VAL A 4 REMARK 465 GLU A 5 REMARK 465 THR A 6 REMARK 465 VAL A 7 REMARK 465 ILE A 8 REMARK 465 ASP A 9 REMARK 465 GLY A 10 REMARK 465 ILE A 11 REMARK 465 ASN A 12 REMARK 465 TYR A 13 REMARK 465 PHE A 14 REMARK 465 LEU A 15 REMARK 465 SER A 16 REMARK 465 LEU A 17 REMARK 465 SER A 18 REMARK 465 VAL A 19 REMARK 465 THR A 20 REMARK 465 GLN A 21 REMARK 465 GLN A 22 REMARK 465 ILE A 23 REMARK 465 SER A 24 REMARK 465 ALA A 430 REMARK 465 ALA A 431 REMARK 465 ALA A 432 REMARK 465 LYS A 433 REMARK 465 ALA A 434 REMARK 465 ASN A 435 REMARK 465 SER A 436 REMARK 465 VAL A 437 REMARK 465 SER A 438 REMARK 465 PHE A 439 REMARK 465 ASN A 440 REMARK 465 SER A 441 REMARK 465 THR A 525 REMARK 465 CYS A 526 REMARK 465 MET A 527 REMARK 465 PHE A 528 REMARK 465 GLY A 529 REMARK 465 GLY A 530 REMARK 465 ARG A 531 REMARK 465 HIS A 532 REMARK 465 HIS A 533 REMARK 465 HIS A 534 REMARK 465 HIS A 535 REMARK 465 HIS A 536 REMARK 465 HIS A 537 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 336 OG SER A 361 1.97 REMARK 500 OD1 ASN A 237 NH2 ARG A 246 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 26 31.41 -80.46 REMARK 500 ARG A 44 106.79 -54.88 REMARK 500 TRP A 57 -37.34 74.03 REMARK 500 ALA A 62 -74.45 -66.88 REMARK 500 SER A 74 -5.86 -49.16 REMARK 500 PHE A 83 -174.26 -175.05 REMARK 500 PHE A 85 141.61 -172.68 REMARK 500 LEU A 121 -61.83 -91.88 REMARK 500 ILE A 131 -91.49 55.81 REMARK 500 LEU A 150 57.21 -116.31 REMARK 500 PHE A 176 -61.99 -124.08 REMARK 500 LYS A 177 59.48 38.95 REMARK 500 LYS A 226 1.22 -57.77 REMARK 500 VAL A 234 -31.24 -132.20 REMARK 500 ARG A 265 -72.40 -57.97 REMARK 500 ASP A 269 67.33 -104.02 REMARK 500 ARG A 274 -79.93 -156.90 REMARK 500 ILE A 282 -74.81 -46.82 REMARK 500 SER A 284 33.34 -166.30 REMARK 500 LYS A 326 63.73 -111.30 REMARK 500 ASP A 347 -176.54 63.33 REMARK 500 HIS A 373 54.97 -143.98 REMARK 500 SER A 405 74.54 -161.71 REMARK 500 PRO A 406 -8.84 -57.50 REMARK 500 PHE A 422 91.50 -67.88 REMARK 500 ARG A 426 -3.74 -53.68 REMARK 500 ASP A 428 -162.99 -103.62 REMARK 500 ASP A 443 -156.89 -74.65 REMARK 500 GLN A 479 -76.05 -72.63 REMARK 500 ASP A 496 106.01 58.42 REMARK 500 TYR A 498 16.99 54.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 SER A 216 PHE A 217 136.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 601 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 470 SG REMARK 620 2 HEM A 601 NA 99.4 REMARK 620 3 HEM A 601 NB 92.3 89.8 REMARK 620 4 HEM A 601 NC 86.9 170.9 96.5 REMARK 620 5 HEM A 601 ND 97.9 81.4 167.5 91.3 REMARK 620 6 1YN A 602 N39 172.6 73.3 89.1 100.1 79.8 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1YN A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5JLC RELATED DB: PDB REMARK 900 5JLC CONTAINS THE HOMOLOGOUS PROTEIN FROM CANDIDA GLABRATA REMARK 900 RELATED ID: 5EQB RELATED DB: PDB REMARK 900 5JLC CONTAINS THE HOMOLOGOUS PROTEIN FROM SACCHAROMYCES CEREVISIAE DBREF 5V5Z A 1 528 UNP P10613 CP51_CANAL 1 528 SEQADV 5V5Z GLY A 529 UNP P10613 EXPRESSION TAG SEQADV 5V5Z GLY A 530 UNP P10613 EXPRESSION TAG SEQADV 5V5Z ARG A 531 UNP P10613 EXPRESSION TAG SEQADV 5V5Z HIS A 532 UNP P10613 EXPRESSION TAG SEQADV 5V5Z HIS A 533 UNP P10613 EXPRESSION TAG SEQADV 5V5Z HIS A 534 UNP P10613 EXPRESSION TAG SEQADV 5V5Z HIS A 535 UNP P10613 EXPRESSION TAG SEQADV 5V5Z HIS A 536 UNP P10613 EXPRESSION TAG SEQADV 5V5Z HIS A 537 UNP P10613 EXPRESSION TAG SEQRES 1 A 537 MET ALA ILE VAL GLU THR VAL ILE ASP GLY ILE ASN TYR SEQRES 2 A 537 PHE LEU SER LEU SER VAL THR GLN GLN ILE SER ILE LEU SEQRES 3 A 537 LEU GLY VAL PRO PHE VAL TYR ASN LEU VAL TRP GLN TYR SEQRES 4 A 537 LEU TYR SER LEU ARG LYS ASP ARG ALA PRO LEU VAL PHE SEQRES 5 A 537 TYR TRP ILE PRO TRP PHE GLY SER ALA ALA SER TYR GLY SEQRES 6 A 537 GLN GLN PRO TYR GLU PHE PHE GLU SER CYS ARG GLN LYS SEQRES 7 A 537 TYR GLY ASP VAL PHE SER PHE MET LEU LEU GLY LYS ILE SEQRES 8 A 537 MET THR VAL TYR LEU GLY PRO LYS GLY HIS GLU PHE VAL SEQRES 9 A 537 PHE ASN ALA LYS LEU SER ASP VAL SER ALA GLU ASP ALA SEQRES 10 A 537 TYR LYS HIS LEU THR THR PRO VAL PHE GLY LYS GLY VAL SEQRES 11 A 537 ILE TYR ASP CYS PRO ASN SER ARG LEU MET GLU GLN LYS SEQRES 12 A 537 LYS PHE ALA LYS PHE ALA LEU THR THR ASP SER PHE LYS SEQRES 13 A 537 ARG TYR VAL PRO LYS ILE ARG GLU GLU ILE LEU ASN TYR SEQRES 14 A 537 PHE VAL THR ASP GLU SER PHE LYS LEU LYS GLU LYS THR SEQRES 15 A 537 HIS GLY VAL ALA ASN VAL MET LYS THR GLN PRO GLU ILE SEQRES 16 A 537 THR ILE PHE THR ALA SER ARG SER LEU PHE GLY ASP GLU SEQRES 17 A 537 MET ARG ARG ILE PHE ASP ARG SER PHE ALA GLN LEU TYR SEQRES 18 A 537 SER ASP LEU ASP LYS GLY PHE THR PRO ILE ASN PHE VAL SEQRES 19 A 537 PHE PRO ASN LEU PRO LEU PRO HIS TYR TRP ARG ARG ASP SEQRES 20 A 537 ALA ALA GLN LYS LYS ILE SER ALA THR TYR MET LYS GLU SEQRES 21 A 537 ILE LYS SER ARG ARG GLU ARG GLY ASP ILE ASP PRO ASN SEQRES 22 A 537 ARG ASP LEU ILE ASP SER LEU LEU ILE HIS SER THR TYR SEQRES 23 A 537 LYS ASP GLY VAL LYS MET THR ASP GLN GLU ILE ALA ASN SEQRES 24 A 537 LEU LEU ILE GLY ILE LEU MET GLY GLY GLN HIS THR SER SEQRES 25 A 537 ALA SER THR SER ALA TRP PHE LEU LEU HIS LEU GLY GLU SEQRES 26 A 537 LYS PRO HIS LEU GLN ASP VAL ILE TYR GLN GLU VAL VAL SEQRES 27 A 537 GLU LEU LEU LYS GLU LYS GLY GLY ASP LEU ASN ASP LEU SEQRES 28 A 537 THR TYR GLU ASP LEU GLN LYS LEU PRO SER VAL ASN ASN SEQRES 29 A 537 THR ILE LYS GLU THR LEU ARG MET HIS MET PRO LEU HIS SEQRES 30 A 537 SER ILE PHE ARG LYS VAL THR ASN PRO LEU ARG ILE PRO SEQRES 31 A 537 GLU THR ASN TYR ILE VAL PRO LYS GLY HIS TYR VAL LEU SEQRES 32 A 537 VAL SER PRO GLY TYR ALA HIS THR SER GLU ARG TYR PHE SEQRES 33 A 537 ASP ASN PRO GLU ASP PHE ASP PRO THR ARG TRP ASP THR SEQRES 34 A 537 ALA ALA ALA LYS ALA ASN SER VAL SER PHE ASN SER SER SEQRES 35 A 537 ASP GLU VAL ASP TYR GLY PHE GLY LYS VAL SER LYS GLY SEQRES 36 A 537 VAL SER SER PRO TYR LEU PRO PHE GLY GLY GLY ARG HIS SEQRES 37 A 537 ARG CYS ILE GLY GLU GLN PHE ALA TYR VAL GLN LEU GLY SEQRES 38 A 537 THR ILE LEU THR THR PHE VAL TYR ASN LEU ARG TRP THR SEQRES 39 A 537 ILE ASP GLY TYR LYS VAL PRO ASP PRO ASP TYR SER SER SEQRES 40 A 537 MET VAL VAL LEU PRO THR GLU PRO ALA GLU ILE ILE TRP SEQRES 41 A 537 GLU LYS ARG GLU THR CYS MET PHE GLY GLY ARG HIS HIS SEQRES 42 A 537 HIS HIS HIS HIS HET HEM A 601 43 HET 1YN A 602 49 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM 1YN 2-[(2R)-BUTAN-2-YL]-4-{4-[4-(4-{[(2R,4S)-2-(2,4- HETNAM 2 1YN DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3- HETNAM 3 1YN DIOXOLAN-4-YL]METHOXY}PHENYL)PIPERAZIN-1-YL]PHENYL}-2, HETNAM 4 1YN 4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE HETSYN HEM HEME HETSYN 1YN ITRACONAZOLE FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 1YN C35 H38 CL2 N8 O4 HELIX 1 AA1 LEU A 27 TYR A 41 1 15 HELIX 2 AA2 SER A 60 GLY A 65 1 6 HELIX 3 AA3 GLN A 67 GLY A 80 1 14 HELIX 4 AA4 LEU A 96 PHE A 105 1 10 HELIX 5 AA5 ALA A 114 GLY A 127 1 14 HELIX 6 AA6 PRO A 135 LYS A 147 1 13 HELIX 7 AA7 PHE A 148 LEU A 150 5 3 HELIX 8 AA8 THR A 151 ASP A 173 1 23 HELIX 9 AA9 VAL A 188 PHE A 205 1 18 HELIX 10 AB1 GLY A 206 ILE A 212 1 7 HELIX 11 AB2 PHE A 217 LYS A 226 1 10 HELIX 12 AB3 GLY A 227 PHE A 228 5 2 HELIX 13 AB4 THR A 229 VAL A 234 5 6 HELIX 14 AB5 LEU A 240 GLU A 266 1 27 HELIX 15 AB6 ASP A 275 HIS A 283 1 9 HELIX 16 AB7 THR A 293 LYS A 326 1 34 HELIX 17 AB8 PRO A 327 GLY A 345 1 19 HELIX 18 AB9 ASP A 347 LEU A 351 5 5 HELIX 19 AC1 THR A 352 GLN A 357 1 6 HELIX 20 AC2 LEU A 359 HIS A 373 1 15 HELIX 21 AC3 SER A 405 THR A 411 1 7 HELIX 22 AC4 ASP A 423 ASP A 428 5 6 HELIX 23 AC5 GLY A 465 ARG A 469 5 5 HELIX 24 AC6 GLY A 472 ASN A 490 1 19 SHEET 1 AA1 3 VAL A 82 PHE A 83 0 SHEET 2 AA1 3 LYS A 90 TYR A 95 -1 O VAL A 94 N PHE A 83 SHEET 3 AA1 3 MET A 86 LEU A 87 -1 N LEU A 87 O LYS A 90 SHEET 1 AA2 5 VAL A 82 PHE A 83 0 SHEET 2 AA2 5 LYS A 90 TYR A 95 -1 O VAL A 94 N PHE A 83 SHEET 3 AA2 5 TYR A 401 VAL A 404 1 O TYR A 401 N THR A 93 SHEET 4 AA2 5 ILE A 379 VAL A 383 -1 N ARG A 381 O VAL A 402 SHEET 5 AA2 5 VAL A 112 SER A 113 -1 N SER A 113 O LYS A 382 SHEET 1 AA3 3 HIS A 183 ASN A 187 0 SHEET 2 AA3 3 GLU A 517 LYS A 522 -1 O TRP A 520 N GLY A 184 SHEET 3 AA3 3 LEU A 491 THR A 494 -1 N THR A 494 O ILE A 519 SHEET 1 AA4 2 LEU A 387 ARG A 388 0 SHEET 2 AA4 2 ILE A 395 VAL A 396 -1 O VAL A 396 N LEU A 387 SHEET 1 AA5 2 GLU A 444 VAL A 445 0 SHEET 2 AA5 2 VAL A 452 SER A 453 -1 O VAL A 452 N VAL A 445 SHEET 1 AA6 2 PRO A 503 ASP A 504 0 SHEET 2 AA6 2 LEU A 511 PRO A 512 -1 O LEU A 511 N ASP A 504 LINK SG CYS A 470 FE HEM A 601 1555 1555 2.36 LINK FE HEM A 601 N39 1YN A 602 1555 1555 2.19 CISPEP 1 GLU A 514 PRO A 515 0 9.33 SITE 1 AC1 17 PHE A 105 TYR A 118 TYR A 132 LEU A 139 SITE 2 AC1 17 LYS A 143 ILE A 304 GLY A 308 THR A 311 SITE 3 AC1 17 PRO A 375 ILE A 379 ARG A 381 PRO A 462 SITE 4 AC1 17 PHE A 463 HIS A 468 CYS A 470 ILE A 471 SITE 5 AC1 17 1YN A 602 SITE 1 AC2 18 ALA A 61 TYR A 118 ILE A 131 TYR A 132 SITE 2 AC2 18 PRO A 230 PHE A 233 GLY A 303 ILE A 304 SITE 3 AC2 18 GLY A 307 THR A 311 LEU A 376 HIS A 377 SITE 4 AC2 18 SER A 378 PHE A 380 TYR A 505 SER A 506 SITE 5 AC2 18 MET A 508 HEM A 601 CRYST1 91.940 92.510 101.530 90.00 90.00 90.00 P 2 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010877 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010810 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009849 0.00000